[{"Assets_0_Q2_USD":82676000.0,"CommonStockSharesOutstanding_0_Q2_shares":8859141.0,"EarningsPerShareBasic_1_Q2_USD":-0.86,"EarningsPerShareBasic_2_Q2_USD":-1.91,"EarningsPerShareDiluted_1_Q2_USD":-0.86,"EarningsPerShareDiluted_2_Q2_USD":-1.91,"NetIncomeLoss_1_Q2_USD":-6176000.0,"NetIncomeLoss_2_Q2_USD":-12847000.0,"StockholdersEquity_0_Q2_USD":75253000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":7171610.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":6734555.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":7171610.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":6734555.0,"Ticker":"ALBO","CIK":"1322505","name":"ALBIREO PHARMA, INC.","OfficialName":"Albireo Pharma Inc. Common Stock","form":"10-Q","period":"20170630","fy":"2017.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"688702712.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20170821"}]